23.10.2012 • NewsDSMRoyal DSMCoatings

DSM Increases Capacity for Solar Coatings

Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it is increasing the installed manufacturing capacity for KhepriCoat anti-reflective coating.

The additional capacity is expected to be on stream by the end of 2012 at the Chemelot site in Geleen, the Netherlands. The need for additional coating supply is a direct result of the fast growing market for solar energy.

KhepriCoat anti-reflective glass coating is an IP protected product, developed by the DSM Innovation Center. The coating is primarily targeted at solar applications. The coating - a thin layer with a thickness of approximately 100 - 150 nm - is applied to the cover glass of solar modules and strongly reduces the reflection of sun-light. As a result, more sun-light passes through the glass, increasing the energy output of these modules by up to 4%.

Solar energy is widely recognized as an important fast-growing alternative and renewable source of energy. Although by the end of this year, worldwide 100GW of PV capacity will be installed (source: EPIA global PV market outlook until 2016) generating around 100TWh, solar energy still has a huge potential for significant further growth.

 

 

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.